Breaking News

You are here » Indian-Commodity  :  Top News  :  Alembic Pharma gets USFDA's nod for Alogliptin, Metformin Hydrochloride Tablets

14-Sep2018

Alembic Pharma gets USFDA's nod for Alogliptin, Metformin Hydrochloride Tablets

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), KAZANO Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg of Takeda Pharma USA. Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg are indicated as an adjunct to diet and exercise to improve giycemic control in adults with type 2 diabetes mellitus when treatment with both alogliptin and metformin is appropriate.

Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg has an estimated market size of $22.5 million for twelve months ending December 2017 according to IQVIA. Alembic now has a total of 77 ANDA approvals (64 final approvals and 13 tentative approvals) from USFDA. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Related News

View all news

Crude oil futures end lower on Tuesday

Crude oil futures ended lower on Tuesday with benchmark finishing at its lowest in over a year, as investor attention remained fixed on supply ahead of a key meeting of major oil producers early next month.......

Copper futures end tad higher on Monday

Copper futures ended slightly higher on Monday, with hopes of a resolution to the US-China trade war outweighing the threat of higher US tariffs on Chinese goods. Copper prices improved further as the......

Gold futures extend winning streak to fourth straight session on Monday

Gold futures extended winning streak to fourth straight session by registering small gains on Monday, amid geopolitical uncertainty and an eased greenback. However, gains were limited due to thin volume......

Top News

View all news

Jumbo Finance gets shareholders' nod to increase borrowing limits up to Rs 30 crore

Jumbo Finance has received an approval to increase Borrowing Limits of the company up-to Rs 30 crore. The shareholders of the company at their meeting held on November 19, 2018, approved the same.Jumbo......

Alembic Pharma gets USFDA's nod for Vardenafil Hydrochloride Orally Disintegrating Tablets

Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Orally Disintegrating Tablets,......

SRF expects total Rs 28 crore quantum of damage due to Cyclone GAJA

SRF is expecting a total Rs 28 crore quantum of damage caused, based on the initial assessment. The disruption of operations was due to Cyclone GAJA at the plant of Technical Textiles Business (Viralimalai)......